Raymond James & Associates Haleon PLC Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HLN
# of Institutions
708Shares Held
468MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.4 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$283 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$203 Million1.62% of portfolio
-
Morgan Stanley New York, NY17.7MShares$160 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$150 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $41.6B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...